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Abstract
Aims Heart failure with preserved ejection fraction is still a diagnostic and therapeutic challenge, and accurate non-invasive
diagnosis of left ventricular (LV) diastolic dysfunction (DD) remains difficult. The current study aimed at identifying the most
informative cardiovascular magnetic resonance (CMR) parameters for the assessment of LVDD.
Methods and results We prospectively included 50 patients and classified them into three groups: with DD (DD+, n = 15),
without (DD, n = 26), and uncertain (DD±, n = 9). Diagnosis of DD was based on echocardiographic E/E′, invasive LV
end-diastolic pressure, and N-terminal pro-brain natriuretic peptide. CMR was performed at 1.5 T to assess LV and left atrial
(LA) morphology, LV diastolic strain rate (SR) by tissue tracking and tagging, myocardial peak velocities by tissue phase map-
ping, and transmitral inflow profile using phase contrast techniques. Statistics were performed only on definitive DD+ and
DD (total number 41). DD+ showed enlarged LA with LA end-diastolic volume/height performing best to identify DD+ with
a cut-off value of ≥0.52 mL/cm (sensitivity = 0.71, specificity = 0.84, and area under the receiver operating characteristic
curve = 0.75). DD+ showed significantly reduced radial (inferolateral E peak: DD: 14.5 ± 6.5%/s vs. DD+: 10.9 ± 5.9%/s,
P = 0.04; anterolateral A peak: DD: 4.2 ± 1.6%/s vs. DD+: 3.1 ± 1.4%/s, P = 0.04) and circumferential (inferolateral A peak:
DD: 3.8 ± 1.2%/s vs. DD+: 2.8 ± 0.8%/s, P = 0.007; anterolateral A peak: DD: 3.5 ± 1.2%/s vs. DD+: 2.5 ± 0.8%/s, P = 0.048) SR
in the basal lateral wall assessed by tissue tracking. In the same segments, DD+ showed lower peak myocardial velocity by tis-
sue phase mapping (inferolateral radial peak: DD: 3.6 ± 0.7 ms vs. DD+: 2.8 ± 1.0 ms, P = 0.017; anterolateral longitudinal
peak: DD: 5.0 ± 1.8 ms vs. DD+: 3.4 ± 1.4 ms, P = 0.006). Tagging revealed reduced global longitudinal SR in DD+
(DD: 45.8 ± 12.0%/s vs. DD+: 34.8 ± 9.2%/s, P = 0.022). Global circumferential and radial SR by tissue tracking and tagging,
LV morphology, and transmitral flow did not differ between DD+ and DD.
Conclusions Left atrial size and regional quantitative myocardial deformation applying CMR identified best patients with DD.
Keywords Diastolic dysfunction; Cardiovascular magnetic resonance; Tissue tracking; Left atrium; Myocardial deformation; Heart
failure with preserved ejection fraction
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Introduction
Heart failure (HF) with preserved ejection fraction (HFpEF) is
prevalent in up to 50% of HF patients.1 According to the
2016 European Society of Cardiology guidelines for the
diagnosis and treatment of acute and chronic HF, HFpEF is
defined as the presence of symptoms or signs of HF com-
bined with left ventricular ejection fraction (LVEF) ≥ 50%
and evidence of left ventricular (LV) diastolic dysfunction
(DD).2 In contrast to HF with reduced ejection fraction,
survival of HFpEF could not be improved in the last de-
cades, although mortality is comparable between both
groups.1 The causes are complex and still subject of active
research. In 2007, it was recommended to diagnose DD
based on either invasive quantification of LV end-diastolic
pressure or echocardiographic evaluation of LV diastolic
function using the ratio (E/E′) of early transmitral flow
velocity (E) assessed by blood flow Doppler to tissue
Doppler-derived early diastolic lengthening velocities (E′) or
by combination of echocardiographic parameters and
N-terminal pro-brain natriuretic peptide as HF biomarker.2
The non-invasive diagnosis remains challenging, even
though different innovative parameters were introduced ap-
plying echocardiography3 as well as cardiovascular magnetic
resonance (CMR).
CMR has the capability to identify and differentiate
myocardial injury already in preserved ejection fraction as
reflected in the recent guidelines of chronic HF.4 It is also
known as the gold standard for assessment of LV volume
and function and offers various techniques to characterize
the myocardium. Assessment of DD applying CMR is not
yet a clinical routine. Different approaches were evaluated
and mostly compared with echocardiography as the diag-
nostic standard.5,6
Similar to Doppler echocardiography, CMR is able to
quantify transmitral flow using phase contrast (PC) imaging
techniques. Early and late diastolic flow velocity peaks can
be quantified and used for evaluation of LV diastolic
function.7 CMR tissue phase mapping (TPM) offers the pos-
sibility to assess velocities of myocardial deformation.8 CMR
tagging allows the quantification of myocardial strain based
on an intrinsic tissue grid generated by magnetization satu-
ration of specific myocardial localizations.9 Tissue tracking is
a recently introduced post-processing method to quantify
myocardial strain. It is based on voxel-related quantification
of myocardial deformation using standard cine CMR
images.10
Several studies have demonstrated the applicability of
these techniques to evaluate diastolic LV function in both
healthy8,11 and diseased patients,12–18 using different
comparators.
The aim of our study was to evaluate the capability of dif-
ferent CMR parameters and techniques to detect DD.
Methods
Study population
Patients aged between 18 and 85 years with indication for
elective left heart catheterization including coronary angiog-
raphy were screened and prospectively enrolled into the
study. Inclusion criterion was a preserved LVEF ≥ 50%. Exclu-
sion criteria included common contraindications for CMR,
pregnancy, cardiac arrhythmia, left bundle branch block, pre-
viously known infarction scars located at the lateral or septal
LV wall, pericardial disease, moderate to severe valvular heart
disease, history of valvular or bypass surgery, severe liver dis-
ease, impaired renal function (estimated glomerular filtration
rate <60 mL/min/m2), severe pulmonary disease (≥COPD
GOLD II), pulmonary arterial hypertension, active cancer, or
severe infections.
We identified patients with (DD+), without (DD), or un-
certain (DD±) DD according to Paulus et al.2 by quantification
of echocardiographic E/E′, invasive LV end-diastolic pressure,
and N-terminal pro-brain natriuretic peptide (Figure 1A). A
6min walk test was performed to objectify functional exercise
capacity according to the guidelines of the American Thoracic
Society. We aimed at completing the whole study protocol
within 24 h (Figure 1B).
Written informed consent was obtained from all patients.
The study was approved by the institutional ethical board
and complies with the Declaration of Helsinki.
Cardiovascular magnetic resonance
CMR was performed on a clinical 1.5 T MR scanner (Avanto,
Siemens Healthineers, Erlangen, Germany) using a
12-channel phased-array coil. Image data were acquired
electrocardiogram-gated and in end-expiratory breath-hold.
Assessment of the left ventricle and the left atrium
To assess LV and left atrial (LA) morphology and function, we
acquired three long-axis (LAX) planes in two-chamber, three-
chamber, and four-chamber views of the LV as well as two
stacks of short-axis (SAX) views covering the entire LV or LA,
respectively, using standard cine steady-state free precession
(SSFP) sequences [temporal resolution 34.7 ms; echo time
(TE) 1.2 ms; field of view (FOV) 292 × 360 mm2; LAX: slice
thickness 6 mm and matrix 156 × 192//LV SAX: slice thickness
7 mm, spacing 3 mm, and matrix 208 × 256; and LA SAX: slice
thickness 5 mm, no gap19].
Left ventricular cine images for tissue tracking
Cine SSFP images in LAX four-chamber views and three SAX
slices (basal, midventricular, and apical) were acquired with
a high temporal resolution of 13.8 ms (TE 1.2 ms, 64 phases,
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matrix 208 × 256, FOV 325 × 400 mm2, slice thickness 8 mm,
and in-plane resolution 1.6 × 1.6 mm2) to evaluate diastolic
strain rate (SR) by tissue tracking.
Tagging
LAX four-chamber views and three SAX slices (basal, midven-
tricular, and apical) were used to perform SSFP spatial modu-
lation of magnetization (SPAMM) tagging and complementary
SPAMM (CSPAMM) tagging for evaluation of diastolic SR
(temporal resolution SPAMM/CSPAMM 21.1 ms/42.3 ms, TE
1.3 ms, matrix 256 × 256, FOV 300 × 300 mm2, slice thickness
6 mm, flip angle 20°, tag spacing 7 mm, and one slice per
breath-hold).20
Tissue phase mapping
TPM imaging of three SAX slices (basal, midventricular, and
apical) was acquired to assess myocardial peak velocities
using a black blood prepared gradient echo TPM sequence
[temporal resolution of 17.1 ms, TE 3.9 ms, matrix
120 × 160, FOV 255 × 340 mm2, slice thickness 8 mm, velocity
encoding (VENC) in-plane 15 cm/s, VENC through plane
25 cm/s, and one slice per breath-hold].15
Phase contrast—transmitral flow
We performed PC imaging in basal SAX positioned at the level
of the mitral valve tips during end-diastole and perpendicular
to the transmitral inflow to analyse transmitral flow velocities
(temporal resolution of 17.4 ms, TE 2.4 ms, 64 phases, matrix
176 × 256, FOV 220 × 320 mm2, slice thickness 5.5 mm,
in-plane resolution 1.3 × 1.3 mm2, and VENC 120 cm/s).
Two more SAX slices were acquired above and below this
slice without gap. Each acquisition was repeated a second
time.
Figure 1 (A) Study group definition and number of patients. (B) Study protocol. LVEDP, left ventricular end-diastolic pressure; NT-proBNP, N-terminal
pro-brain natriuretic peptide.
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Post-processing analysis
Assessment of the left ventricle and the left atrium
Analysis of LV and LA morphology was performed with com-
mercially available software (cvi42 Version 4.1.3, Circle Car-
diovascular Imaging Inc., Calgary, Canada). LV epicardial and
endocardial contours were traced manually in end-systole
and end-diastole to assess LV mass (LVM), LV end-diastolic
volume (LVEDV) and LV end-systolic volume, LV stroke vol-
ume, LVEF, and LV remodelling index as the ratio of LVEDV
and LVM.21,22 Papillary muscles were traced separately.
The stack of LA SAX was analysed similarly. LA systole and
LA diastole were defined as phases of minimal or maximal
LA dimensions. Pulmonary veins and atrial appendage were
excluded.23 LA minimal and maximum volumes (LA-EDV), LA
stroke volume, and LA ejection fraction were assessed. Nor-
malization to body surface area (BSA) and body height (H)
was performed for LVM, LVEDV, LV end-systolic volume, and
the volumetric LA parameters.
LA area was measured in the LAX cine SSFP images in the
two-chamber, three-chamber, and four-chamber views. Pul-
monary veins were excluded, and LA appendage was
included.19 Longitudinal and transversal diameters were de-
fined in two-chamber and four-chamber views as well.19
Tissue tracking
Two-dimensional tissue tracking was performed using cvi42
prototype 5.3.0 (Circle Cardiovascular Imaging Inc.).
End-diastolic contours of LV endocardium and epicardium
were defined in all slices excluding papillary muscles. For re-
gional analysis, a basal SAX reference point was set at the an-
terior insertion of the right ventricle. The deformation
analysis was performed automatically. Radial (Err) and circum-
ferential (Ecc) myocardial deformation were evaluated based
on SAX analysis, LAX four-chamber view was used to assess
longitudinal (Ell) strain parameters. Global preE, E, and A
peaks of diastolic SR were defined as shown in Figure 2C. SR
peaks were determined manually for each slice and each di-
rection of movement.
The analysis was performed both per slice and per segment
to identify regional differences. The segmentation was based
on the 16-segment model according to the American Heart
Association.24 We excluded the assessment of preE in the re-
gional evaluation but determined the maximum peak (Ecc
max and Err max) during the whole diastolic phase (time be-
tween aortic valve closure and mitral valve closure). In case
of undefinable E and A, only maximum peaks during the
whole diastole were assessed.
Tagging
Tagging images were analysed using CIM Tag2D Heart Defor-
mation WIP20 (Heart Deformation post-processing prototype
2.0, Auckland MRI Research Group, University of Auckland,
Auckland, New Zealand). LV endocardium and epicardium as
well as insertions of the right ventricle were defined in end-
diastole. Myocardial tags were contoured semi-automatically
in all phases of each slice. To achieve a maximum accordance
of image tag lines and overlaid analysing grid, the model
stripes were adapted every second (CSPAMM) to fourth
(SPAMM) frame using additional guide points.18 We gener-
ated Ecc SR from SAX and Ell SR out of LAX four-chamber view
images. Peak diastolic SR was defined as first peak after end-
systole. Global and segmental (six segments per slice) analy-
ses were performed.
Tissue phase mapping
Post-processing analysis was performed using MATLAB (The
MathWorks, Inc., Natick, MA, USA). Epicardial and endocar-
dial contours were defined semi-automatically for each phase
of each slice before starting myocardial velocity measure-
ments as described recently.15 Peak diastolic radial (Vr) and
longitudinal (Vz) velocities were assessed for global and seg-
mental analysis. Regional analysis was based on the
16-segment model according to the American Heart
Association.24
Phase contrast—transmitral flow
cvi42 (Version 4.1.3, Circle Cardiovascular Imaging Inc.) was
used to perform post-processing analysis of PC velocity mea-
surements. The slice showing best the mitral valve tip separa-
tion was chosen. Regions of interest were set
semi-automatically based on colour-coded display of
transmitral blood flow. Early (E) and late (A) diastolic peak ve-
locities were derived from transmitral flow velocity curves.
For statistical analysis, we used mean values of repeated mea-
surements of E, A, and the ratio E/A.
Non-diagnostic images due to breath-hold artefacts or
malpositioning were excluded.
Statistical analysis
Statistical analyses were performed by relying only on DD+
(n = 15) and DD (n = 26, i.e. in total 41 patients) groups as
our aim was to identify a CMR parameter, which would best
meet the published criteria to identify definite DD. Data are
shown as mean ± standard deviation. Statistical tests were
performed using IBM SPSS Statistics 25 (IBM Corp., Armonk,
NY, USA). Mann–Whitney U test was used for analysis of
group differences, whereas significance was stated at
P < 0.05. Correlation analysis was performed using the Spear-
man correlation coefficient. Receiver operating characteristic
(ROC) curve analyses were established to define cut-off
values. As the aim of this study was the identification of pa-
rameters with discriminatory power, no formal sample size
calculation was performed.
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Figure 2 Overview cardiovascular magnetic resonance techniques. Left ventricular–midventricular short-axis view of myocardial deformation via tag-
ging in (A1) end-diastole and (A2) end-systole. Left ventricular–midventricular short-axis view of colour-encoded myocardial velocity tissue phase map-
ping in (B1) end-diastole and (B2) end-systole. Assessment of cardiovascular magnetic resonance tissue tracking: (C1) end-diastolic contouring and tissue
tracking and (C2) end-systolic myocardial deformation. (C3) Radial strain and (C4) strain rate: the graphs show phases of one cardiac cycle. The defi-
nitions were as follows: end-systole = phase of aortic valve closure; isovolumetric relaxation time (IVRT) = time between end-systole and mitral valve
opening; and end-diastole = phase of mitral valve closure. Peaks of myocardial strain rate were defined as follows: (i) preE = peak within IVRT; (ii)
E = peak between mitral valve opening and start of diastolic plateau phase; and (iii) A = peak between end of diastolic plateau phase and end-diastole.
(D) Stack of short-axis views of left atrial (LA) and contouring in LA diastolic phase. (E) Measurement of LA plane and diameters in long-axis two-cham-
ber, three-chamber, and four-chamber views. (F) Assessment of phase contract transmitral flow velocities: basal short-axis views with and without
colour-encoded visualization and contouring of the mitral annulus; transmitral flow velocity curve with early (E) and late (A) diastolic peak velocities.
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Results
Study population
We screened 741 patients with an indication for LV catheter-
ization between May 2013 and June 2014. Fifty-nine met our
criteria and were included, with 39% having their first invasive
procedure due to suspected coronary artery disease and 61%
having suspicion of progression of their known coronary ar-
tery disease. Nine out of these 59 patients dropped out be-
cause of arrhythmia, EF < 50% as defined by CMR,
claustrophobia, aortic stenosis, or increased LVEDV index,
resulting in n = 50 as the final sample. We finally identified
26 DD, 15 DD+, and 9 DD±. DD+ showed significant higher
body mass index compared with DD. For detailed demo-
graphics, see Table 1. In 40 out of 50 cases, examinations
could be performed within 24 h (mean 25.4 h; range 16.3–
91.1 h). Walking distance did not differ significantly between
DD+ and DD (P = 0.129). ROC curve analyses showed an
area under the ROC curve (AUC) of 0.663 (Figure 3).
Cardiovascular magnetic resonance analysis
Data analysis was performed in all patients. Detailed data are
given in Supporting Information, Tables S1 and S2.
Assessment of the left ventricle and the left atrium
Two cases had to be excluded. Results are given in Table 2. LV
volumes and LVM did not show significant differences be-
tween DD+ and DD.
Left atrial size was larger in DD+ with significantly higher
LA-EDV and LA area. The difference remained significant
when normalizing to body height. ROC curve analysis (Figure
3) showed best results for LA-EDV/H with a cut-off value of
≥0.52 mL/cm (sensitivity = 0.71, specificity = 0.84,
AUC = 0.75, and accuracy = 0.75) to differentiate between
DD+ and DD.
Tissue tracking
Five cases had to be excluded. Global analysis did not show
significant differences. Results of regional analysis are shown
in Figure 4A. In 53 out of 992 segments, only maximum peaks
during the whole diastole were assessed. DD+ presented im-
paired E and A with significant reductions in basal
inferolateral, anterolateral, and apical anterior segments. Fur-
thermore, Err max of DD+ was significantly lower in the basal
anterolateral segment (DD: 16.5 ± 7.94%/s vs. DD+:
9.8 ± 3.85%/s, P = 0.011).
Tagging
We had to exclude 18 out of 666 segments in SPAMM data
and 24 out of 630 segments in CSPAMM data. SPAMM
showed reduced global Ell SR in DD+ (DD: 45.8 ± 12.0%/s
vs. DD+: 34.8 ± 9.2%/s, P = 0.022). Further global and segmen-
tal amplitude of Ecc and Ell diastolic SR did not differ signifi-
cantly between DD+ and DD (Figure 4C).
Tissue phase mapping
Forty-four out of 560 mostly apical located segments had to
be excluded. The amount of global diastolic peak velocities
reached statistical significance in apical Vz (DD:
2.7 ± 0.6 cm/s vs. DD+: 2.2 ± 1.0 cm/s, P = 0.029). Results
of segmental evaluation are visualized in Figure 4B. Vz and Vr
differ significantly in the basolateral segments.
Table 1 Characteristics of the study population
Study groups
Without diastolic dysfunction (DD) Uncertain diastolic function (DD±) With diastolic dysfunction (DD+)
Sample size (n) 26 9 15
Sex (male|female) 16|10 9|0 9|6
Age (years) 66.6 ± 8.9 68.0 ± 7.3 70.5 ± 7.4
BMI (kg/m2) 26.7 ± 3.0 28.6 ± 4.7 29.7 ± 3.2*
6MWD (m) 509 ± 76 487 ± 114 446 ± 122
LVEDP (mmHg) 8 ± 3 14 ± 1* 20 ± 5* †
E/E′ 8.5 ± 2.0 10.8 ± 1.4* 10.1 ± 2.0*
NT-proBNP (ng/mL) 184 ± 151 157 ± 107* 447 ± 422*
Heart rate (b.p.m.) 68 ± 11 70 ± 11 64 ± 8
Arterial hypertension (%) 84.6 100.0 93.3
Coronary artery disease (%) 88.5 100.0 80.0
One-vessel disease (%) 23.1 33.3 26.7
Two-vessel disease (%) 34.6 55.6 20.0
Three-vessel disease (%) 30.8 11.1 33.3
Diabetes mellitus (%) 34.6 11.1 33.3
Hyperlipoproteinaemia (%) 38.5 66.7 60.0
6MWD, 6 min walking distance; BMI, body mass index; E/E′, ratio of early transmitral flow velocity (E) and early diastolic lengthening ve-
locity (E′); LVEDP, left ventricular end-diastolic pressure; NT-proBNP, N-terminal pro-brain natriuretic peptide.
Data are shown as mean ± standard deviation.
*For P < 0.05 compared with DD.
†For P < 0.05 compared with DD±.
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Phase contrast—transmitral flow
For assessment of transmitral flow, two cases had to be ex-
cluded. Neither E (DD: 0.5 ± 0.1 cm/s vs. DD+:
0.5 ± 0.1 cm/s, P = 0.689) nor A (DD: 0.6 ± 0.2 cm/s vs.
DD+: 0.6 ± 0.2 cm/s, P = 0.753) or E/A (DD: 0.8 ± 0.3 vs.
DD+: 1.1 ± 0.9, P = 0.441) differed significantly between
DD and DD+.
Discussion
CMR provides various techniques to assess cardiac structure and
function.25 In this study, we are providing for the first time a
comparison of CMR parameters of diastolic function with a pub-
lished gold standard including invasive measurements. Based on
the quantification of LA size, a cut-off can be derived to identify
Figure 3 Diagnostic performance of measurements of the left atrium and walking distance to identify diastolic dysfunction. (A) Receiver operating char-
acteristic curves of left atrial (LA) end-diastolic volume (EDV), area of three-chamber view, and triplane mean area indexed to height (H). (B) Receiver
operating characteristic curve of walking distance assessed by 6 min walk test.
Table 2 Findings of LV and LA analysis of DD and DD+
DD DD+ P-value
Left ventricle
LVEDV (mL) 122.6 ± 34.3 130.5 ± 32.4 0.429
LVEDV/BSA (mL/m2) 63.7 ± 14.0 66.3 ± 14.9 0.639
LV-SV (mL) 83.3 ± 21.3 86.0 ± 22.2 0.548
LVEF (%) 69.0 ± 7.6 66.0 ± 7.4 0.334
LVM (g) 96.5 ± 29.9 110.2 ± 30.6 0.092
LVM/H (g/cm) 0.6 ± 0.1 0.7 ± 0.2 0.050
LVM/BSA (g/m2) 49.9 ± 11.3 55.6 ± 12.3 0.079
LVRI (g/mL) 0.8 ± 0.1 0.9 ± 0.2 0.412
Left atrium—quantification based on full coverage (volume)
LA-EDV (mL) 74.4 ± 17.2 93.3 ± 26.2 0.014*
LA-EDV/H (mL/cm) 0.4 ± 0.1 0.6 ± 0.1 0.010*
LA-EDV/BSA (mL/m2) 39.2 ± 8.9 46.6 ± 12.0 0.069
LA-SV (mL) 38.7 ± 8.4 41.2 ± 13.0 0.578
LAEF (%) 52.7 ± 7.4 45.7 ± 13.1 0.151
Left atrium—quantification based on area
LA area 4CV (mm2) 20.1 ± 6.2 22.1 ± 5.4 0.169
LA area 4CV/H (mm2/cm) 0.12 ± 0.03 0.13 ± 0.03 0.188
LA area 3CV (mm2) 18.6 ± 3.8 22.3 ± 5.9 0.033*
LA area 3CV/H (mm2/cm) 0.11 ± 0.02 0.13 ± 0.03 0.026*
LA area 2CV (mm2) 20.4 ± 5.5 24.8 ± 5.6 0.035*
LA area 2CV/H (mm2/cm) 0.12 ± 0.03 0.15 ± 0.03 0.061
LA area mean biplane (mm2) 20.2 ± 5.5 23.5 ± 4,8 0.084
LA area mean biplane/H (m2/cm) 0.12 ± 0.03 0.14 ± 0.03 0.079
LA area mean triplane (mm2) 19.7 ± 4.6 23.1 ± 5.1 0.084
LA area mean triplane/H (m2/cm) 0.12 ± 0.03 0.13 ± 0.03 0.046*
2/3/4CV, two-chamber/three-chamber/four-chamber view; BSA, body surface area; DD, patients without diastolic dysfunction; DD+, pa-
tients with diastolic dysfunction; EDV, end-diastolic volume; H, body height; LA, left atrial; LAEF, left atrial ejection fraction; LV, left ven-
tricular; LVEF, left ventricular ejection fraction; LVM, left ventricular mass; LVRI, left ventricular remodelling index; SV, stroke volume.
Data are shown as mean ± standard deviation.
*For P < 0.05.
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Figure 4 Regional myocardial differences between patients with and without diastolic dysfunction. Significant differences are highlighted in red. (A)
Tissue tracking: early (E) and atrial (A) diastolic peaks of circumferential and radial strain rate ± standard deviation. P-values of segments showing sig-
nificant differences are Ecc A peak: basal inferolateral (P = 0.007) and apical anterior (P = 0.014); Err E peak: basal inferolateral (P = 0.030); and Err A
peak: basal inferolateral (P = 0.033) and apical anterior (P = 0.019). (B) Tissue phase mapping (TPM) radial and longitudinal peak diastolic
velocities ± standard deviation. P-values of segments showing significant differences are Vr basal inferolateral (P = 0.018), Vz basal anterolateral
(P = 0.007), and Vz medial anterior (P = 0.044). (C) Tagging [spatial modulation of magnetization (SPAMM) and complementary spatial modulation
of magnetization (CSPAMM)]: diastolic peak of circumferential strain rate ± standard deviation.
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Figure 4 Continued
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DD. Furthermore, quantification of diastolic LV deformation has
been found to be predictive to identify patients with DD.
Specifically, our main findings are as follows:
i Enlarged LA dimensions of LA-EDV/H ≥ 0.52 mL/cm have a
diagnostic accuracy of 0.75 (AUC = 0.75) on our data to
identify DD.
ii Tissue tracking and TPM reveal impaired diastolic deforma-
tion of the basal lateral wall in DD+ as a direct sign of DD.
LA enlargement is well known in LVDD, caused by a chronic
increase of LV filling pressure due to impaired relaxation and
reduced compliance.26 LA dilatation already is part of the di-
agnostic algorithm of DD in both the consensus statement
of the Heart Failure and Echocardiography Association of
the European Society of Cardiology published in 20072 and
the current recommendations of the American Society of
Echocardiography and the European Association of Cardiovas-
cular Imaging published in 2016.3 They recommended cut-off
values of 40 and 34 mL/m2, respectively, for echocardio-
graphic LA maximal volume indexed to BSA. LA-EDV/BSA did
not show significant differences between DD+ and DD in
our study. Compared with the echocardiographic cut-offs,
both groups reached borderline or higher mean values
(DD: 39.2 ± 8.9 mL/m2 vs. DD+: 46.6 ± 12.0 mL/m2), but
echocardiography is known to show systematically smaller
LA volumes as compared with CMR.27 Furthermore, our DD+
group had a significantly higher body mass index than DD.
Patel et al.28 showed that LA-EDV/BSA underestimates the
prevalence of LA enlargement in obese populations, whereas
the level of obesity did not affect indices to height. As in-
creased LA volume is associated with prognosis and cardiovas-
cular events,26 investigation of LA size is of general
importance. But enlarged LA size is correlated with both
HFpEF and HF with reduced EF.29
In our study, LA volume quantification was based on the
evaluation of a stack of SAX as reported by Maceira et al.19
In principle, it could also be assessed by reliance on transverse
slices, which is mainly used in congenital heart disease and
has also recently been applied in the detection of subclinical
atrial fibrillation.30,31 As a consequence, more subtle differ-
ences that might be captured by transverse slices may have
been missed. Currently, there are no head-to-head compari-
sons published regarding superiority, for example, to predict
outcome. Unfortunately, constraints in scan time did not al-
low to collect scans in the transverse orientation. If scan time
is limited, it is also acceptable to assess LA volume by
two-dimensional area-length method.23
A 6 min walk test is one of the most popular clinical exer-
cise tests.32 It is often used to objectify and compare func-
tional exercise capacity between different groups or before
and after medical interventions. In our study, walking dis-
tance did not differ significantly between DD+ and DD. Fur-
thermore, ROC curve analyses showed numerically better
diagnostic ability for LA-EDV/H than walking distance without
reaching statistical significance.
Echocardiographic E and A peaks of transmitral flow are
part of the clinical standard for estimating LV filling pressure
and grading DD.3 PC imaging is able to assess blood flow
velocities.7 Our study was not designed to compare equiva-
lent echocardiographic and CMR parameters. But previous
studies showed good correlation between echocardiographic
and CMR-derived parameters and a general underestimation
of transmitral flow parameters by CMR.33–35 In our study, E
and A peaks as well as E/A ratio did not differ significantly be-
tween DD+ and DD. Graca et al. studied 48 healthy volun-
teers using CMR and detected a higher prevalence of DD in
men than in women. They defined and graded DD by PC
CMR-derived transmitral E/A ratio, mitral deceleration time,
and LA size.36
Changes in LA morphology and transmitral flow patterns
merely represent a consequence of DD. One would expect
that the evaluation of intrinsic myocardial characteristics of-
fers new insights into DD. In echocardiography, global longitu-
dinal SR is a frequently applied parameter to evaluate
diastolic function and also known for the assessment of sys-
tolic function. It is known to have a significant association
with the time constant of LV relaxation and has been used
to predict outcomes in several disease stages.3 In our study,
we found significantly reduced Ell SR assessed by tagging
SPAMM in DD+. Because of technical limitations, tissue
tracking-derived Ell SR was not reliable in our setting. Future
technical improvements may overcome these limitations.
On the other hand, CMR offers a wide spectrum of addi-
tional parameters to assess diastolic myocardial deformation
applying tagging, tissue tracking, and TPM. Several studies ex-
amined applicability of CMR tagging to evaluate diastolic func-
tion using different diastolic parameters. We focused on peak
early diastolic SR. Diastolic Ecc did not show significant differ-
ences between DD+ and DD. In contrast, both Ennis et al.17
and Edvardsen et al.16 detected significantly decreased early
diastolic Ecc SR in patients suffering from familial hypertro-
phic cardiomyopathy or LV hypertrophy, respectively. Among
other reasons, these divergent findings may be due to differ-
ent study populations, variable degrees of cardiac remodel-
ling, and technical issues including the use of different
approaches.
Tissue tracking is a recently introduced post-processing
technique to evaluate myocardial strain and SR based on SSFP
cine images.10 Segmental analysis of E and A peak Ecc and Err
diastolic SR showed significant reduction in DD+ in the basal
lateral wall. Kuetting et al.12 evaluated global midventricular
early and peak diastolic Ecc SR in patients with
echocardiographically diagnosed DD and controls. Both pa-
rameters appeared significantly reduced in patients with DD.
We did not find similar differences on the midventricular level
of global Ecc. However, healthy controls in the study by
Kutting et al. were younger and Ecc early diastolic SR has been
10 J. Kermer et al.
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shown to decrease with age.11 For this method, comparison
across studies may be misleading as most studies are focusing
on systolic strain and SR as well as due to technical reasons
and different approaches.11,12,37 Similar challenges are known
from other imaging techniques.38,39 A comparison with
healthy volunteers could help to interpret the published liter-
ature, but currently published normal values for segmental di-
astolic SR analysis based on tissue tracking or tagging are
lacking.
The findings in the basal lateral wall using tissue tracking
are supported by the TPM results of our study. TPM has been
shown to be a reliable technique to evaluate and discriminate
myocardial velocities of healthy volunteers and patients.8 The
present study demonstrated impaired Vz in the apical slice.
These findings could only partially be reproduced in a seg-
mental analysis. In contrast, we found significantly reduced
regional diastolic peak velocities again in the basal lateral wall
of DD+. Von Knobelsdorff-Brenkenhoff et al.15 and Foell
et al.13 analysed TPM-derived myocardial velocities in healthy
volunteers and patients with hypertensive heart disease and
preserved EF. Both studies found significantly reduced dia-
stolic Vr and Vz peak velocities in patients. We did not include
healthy volunteers, but patients without signs for DD that
may explain the differing results. The reduced peak velocities
might be caused by the predominant presence of arterial hy-
pertension and higher age. Diastolic Vz and Vr are known to
decrease in the elderly.8 However, the differentiation of
age-dependent reduced relaxation and pathological DD is es-
sential and needs further attention in an ageing society. Po-
tentially, reduced diastolic peak velocities in the basal lateral
wall play a particular role in this differentiation.
In our cohort, reduced myocardial deformation was mainly
detected in the basal lateral segments. Several types of cardio-
myopathy like viral myocarditis40,41 and myocardial dystrophies
such as myotonic dystrophy type 2,42 facioscapulohumeral mus-
cular dystrophy 1,43 and Becker muscular dystrophy44,45 show
focal and subclinical diffuse fibrosis predominantly in the
inferolateral wall. Both focal and diffuse fibrosis have also been
seen in HF with preserved ejection fraction or hypertensive heart
disease.21,46 Furthermore, the myocardial deformation response
to isometric exercise in subjects with hypertensive heart disease
was predominantly abnormal in the lateral segments.15 Taken
together, there is evidence that the inferolateral wall may be a
region of early or increased vulnerability for pathological struc-
tural and functional changes even though up to now amechanis-
tic explanation for this observation is lacking.
To underpin our findings of LA enlargement and impair-
ment of diastolic function in the basal lateral wall, a reclassifi-
cation would have been desirable. But DD± was limited by a
small sample size due to missing data regarding group defin-
ing measurements (n = 4) and exclusions due to technical rea-
sons (see Supporting Information, Table S3). Therefore, the
group of DD± would not have been sufficient to perform a
reclassification.
Beyond the detection of DD itself, graduation of DD could
offer more insights in disease staging and pathophysiology.
Our approach did not focus on grading DD and therefore pa-
tients with Grade I DD were probably missed or went unde-
tected. The identification of borderline cases and
parameters for reclassification should be addressed in future
studies.
Irrespective of a potential future implementation of our pa-
rameters to clinical practice, transthoracic echocardiography
will remain the first-line method to evaluate diastolic func-
tion. But in cases of primarily performed CMR, for example,
in patients with suspected cardiomyopathy, it may be useful
to being able to reliably assess diastolic function as an addi-
tional parameter. CMR scans have to be time efficient in clin-
ical routine, which enhances the potential role of a fast
biplane LA-EDV/H assessment and tissue tracking analyses
with no need for additional image acquisitions.
The present study shows some limitations. First, study re-
sults are based on a small sample size even though demo-
graphic confounders could be excluded. Second, the
definition of study groups was based on the consensus state-
ment by Paulus et al.,2 which shows some minor deviation to
the updated recommendations for evaluation of LV diastolic
function by echocardiography,3 which were published after
realization of the study. Third, we had not the possibility to
run invasive measurements in healthy volunteers; only pa-
tients with clinical indication for left heart catheterization
were screened. As a consequence, by study design, a group
of healthy volunteers with definitive normal diastolic function
is lacking in the current study.
In conclusion, CMR is able to identify patients with DD. En-
larged LA is most predictive for DD among evaluated compre-
hensive CMR parameters. TPM and tissue tracking reflect
intrinsic aberration by revealing impaired deformation pat-
terns in the basal lateral segments in comparison with pa-
tients with normal diastolic function.
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